
Video • Strategic partnership
Unlocking the full potential of EarlyCDT Lung in US
Oncimmune Holdings plc, a leading global immunodiagnostics group, announces it has entered into an exclusive partnership agreement which it believes will unlock the full potential of EarlyCDT Lung in the United States, bringing this lung cancer test to more patients as a result. This agreement with Biodesix, Inc., a leading lung cancer diagnostic solutions company, encompasses both the…